ROSUMAC F5 (Fenofibrate (67mg) + Rosuvastatin (5mg))

Rosumac F 5 Tablet is a therapeutic combination of two medications aimed at reducing lipid levels in the bloodstream, specifically targeting cholesterol and triglycerides. This medication is indicated when modifications in lifestyle, such as adopting a low-fat diet, have not successfully managed lipid levels. By effectively lowering these lipids, Rosumac F 5 Tablet plays a crucial role in decreasing the likelihood of developing heart-related conditions. This medicine can be administered with or without food, allowing flexibility in timing, though it is advisable to maintain a consistent schedule daily to enhance adherence to the treatment regimen. Your healthcare provider will determine the appropriate dose based on your lipid levels and your individual response to the medication. Individuals diagnosed with elevated cholesterol and triglyceride levels may not exhibit any symptoms; however, discontinuation of the treatment can lead to a rise in lipid levels, potentially worsening your condition and elevating the risk for heart disease and stroke. Regular monitoring of lipid profiles is essential while using this medication. It is important to note that this medication is part of a broader treatment strategy, which should include a healthy diet, regular physical activity, cessation of smoking, moderate alcohol consumption, and maintaining a healthy weight. While on this medication, a balanced diet should be prioritized, with an emphasis on avoiding high-fat foods. Some side effects may occur, including nausea, abdominal discomfort, constipation, headaches, increased gas, and muscle aches, but these are generally mild and transient. If any adverse effects persist or if symptoms like jaundice, unusual bleeding, or significant unexplained muscle pain occur, medical advice should be sought. Periodic liver function tests may be recommended throughout the course of treatment. Important contraindications include pre-existing liver conditions; it’s crucial to discuss any kidney issues or if you are pregnant or breastfeeding with your doctor prior to initiating therapy. Diabetic patients should closely monitor their blood sugar levels, as this medication may influence glycemic control.